/stocks — the workspaceLOADING
Vor Biopharma Inc. (VOR) is a biological products, (no diagnostic substances) company. 12 insider Form 4 filings in the last 90 days. Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Not reported in XBRL for this filer.
A plain-English read on VOR plus an auto-SWOT — built from VOR's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate VOR using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Projected from VOR's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment VOR files its announcement.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| RA CAPITAL MANAGEMENT, L.P.Director | SELL | $2.6M | view → |
| RA CAPITAL MANAGEMENT, L.P.Director | SELL | $10.2M | view → |
| RA CAPITAL MANAGEMENT, L.P.Director | SELL | $11.9M | view → |
| RA CAPITAL MANAGEMENT, L.P.Director | SELL | $10.2M | view → |
| RA CAPITAL MANAGEMENT, L.P.Director | SELL | $14.5M | view → |